FKBP14 Human

FK506 Binding Protein 14 Human Recombinant
Cat. No.
BT20056
Source
Escherichia Coli.
Synonyms
FKBP22, FKBP-14, FK506 Binding Protein 14, FKBP14, EC=5.2.1.8, PPlase FKBP14, Peptidyl-prolyl cis-trans isomerase FKBP14, FLJ20731.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

FKBP14 Recombinant E.coli produced in E.Coli is a single, non-glycosylated polypeptide chain containing 213 amino acids (20-211 a.a.) and having a molecular mass of 24.2 kDa. The FKBP14 is fused to 21 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
FKBP14 is an enzyme that accelerates protein folding during protein synthesis. It comprises two EF-hand domains and a PPIase FKBP-type domain. The PPIase FKBP-type domain, crucial for peptidyl prolyl cis-trans isomerase activity, is located at the N-terminus. This is evidenced by the significant decrease in activity observed when the amino-terminus of FKBP14 is truncated.
Description
Recombinant FKBP14, expressed in E. coli, is a single, non-glycosylated polypeptide chain. This protein consists of 213 amino acids (with the sequence spanning from amino acid 20 to 211) and has a molecular weight of 24.2 kDa. For purification purposes, a 21 amino acid His-Tag is fused to the N-terminus of the FKBP14 protein. The purification process employs proprietary chromatographic techniques.
Physical Appearance
The product is a clear, colorless solution that has been sterilized by filtration.
Formulation
The FKBP14 Human solution is provided at a concentration of 1 mg/ml. It is formulated in a buffer containing 1x PBS at pH 7.4 and 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), the product can be stored at 4°C. For longer storage, it is recommended to freeze the product at -20°C. To ensure optimal stability during long-term storage, consider adding a carrier protein such as 0.1% HSA or BSA. Repeated freezing and thawing of the product should be avoided.
Purity
The purity of the FKBP14 protein is determined by SDS-PAGE analysis and is guaranteed to be greater than 90%.
Biological Activity
The specific activity, determined by measuring the enzyme's ability to cleave suc-AAFP-pNA, is greater than 240 nmoles per minute per mg of protein. This assay is conducted at 25°C in Tris-HCl buffer at pH 8.0, using chymotrypsin as a reference.
Synonyms
FKBP22, FKBP-14, FK506 Binding Protein 14, FKBP14, EC=5.2.1.8, PPlase FKBP14, Peptidyl-prolyl cis-trans isomerase FKBP14, FLJ20731.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MALIPEPEVK IEVLQKPFIC HRKTKGGDLM LVHYEGYLEK DGSLFHSTHK HNNGQPIWFT LGILEALKGW DQGLKGMCVG EKRKLIIPPA LGYGKEGKGK IPPESTLIFN IDLLEIRNGP RSHESFQEMD LNDDWKLSKD EVKAYLKKEF EKHGAVVNES HHDALVEDIF DKEDEDKDGF ISAREFTYKH DEL.

Product Science Overview

Structure and Function

FKBP14 is a 22-kilodalton protein that contains several important structural motifs:

  • Peptidyl-prolyl isomerase domain: This domain is responsible for the protein’s enzymatic activity, specifically catalyzing the cis-trans isomerization of proline residues in polypeptide chains. This activity is crucial for proper protein folding and function.
  • EF-hand motifs: These are helix-loop-helix structural domains capable of binding calcium ions, which play a role in various cellular processes.
  • Endoplasmic reticulum (ER) retention signal: This signal ensures that FKBP14 is retained within the ER, where it performs its functions related to protein folding and quality control .
Biological Role

FKBP14 is primarily located in the endoplasmic reticulum and is involved in the folding and assembly of newly synthesized proteins. It acts as a chaperone, assisting in the proper folding of proteins that contain proline residues. This function is essential for maintaining cellular homeostasis and preventing the accumulation of misfolded proteins, which can lead to various diseases.

Clinical Significance

Mutations in the FKBP14 gene have been associated with a rare genetic disorder known as FKBP14-related Ehlers-Danlos syndrome (EDS). This condition is characterized by joint hypermobility, skin hyperextensibility, and other connective tissue abnormalities. The discovery of FKBP14’s role in this syndrome has provided valuable insights into the molecular mechanisms underlying connective tissue disorders .

Research and Applications

FKBP14, like other members of the FKBP family, has been the subject of extensive research due to its involvement in various cellular processes and its potential as a therapeutic target. The ability of FKBP14 to bind immunosuppressive drugs such as FK506 and rapamycin has made it a valuable tool in studying immune regulation and developing new treatments for autoimmune diseases and transplant rejection .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.